论文部分内容阅读
目的分析自身免疫性疾病领域科研投入、文献概貌、治疗药物等信息,了解领域研究现状。方法利用科学计量学方法,分析SCIE数据库收录的论文情况,同时还分析了科研投入和治疗药物等信息。结果 2007年至2010年,美国NIH年资助金额在7~9亿美元,跨国医药公司对该领域研究也给予了相当大的支持。中国在该领域支持力度也较大。全球上市药物有233种。近10年来,科技论文呈小幅增长趋势,美国实力最强,中国发文量排在第9位,但被引频次较低,并且还没有形成核心研究机构。结论我国应继续加大自身免疫性疾病领域的科研投入,并积极引导市场化资金参与。在发文量增加的同时,还要注重提高发文质量。
Objective To analyze the research investment, literature overview and therapeutic drugs in the field of autoimmune diseases so as to understand the research status in the field. Methods Using the methods of scientometrics, this paper analyzed the papers collected in SCIE database, analyzed the input of scientific research and the treatment of drugs. Results From 2007 to 2010, the amount of NIH subsidy in the United States was between 700 million and 900 million U.S. dollars. Multinational pharmaceutical companies also gave considerable support to the research in this field. China has also made great efforts in this area. There are 233 drugs listed in the world. In the past 10 years, there has been a slight increase in science and technology papers. The United States has the strongest strength and the number of Chinese papers published in the 9th place. However, it has been cited a relatively low frequency and has not formed a core research institute. Conclusion China should continue to increase investment in scientific research in the field of autoimmune diseases and actively guide the participation of market-oriented funds. While increasing the amount of sending documents, we should also pay attention to improving the quality of sending documents.